Eledon Pharmaceuticals
€2.5
17
-€0.1-3.85% Today
Statistics
Day High
2.3
Day Low
2.3
52W High
3.7
52W Low
1.17
Volume
-
Avg. Volume
-
Mkt Cap
149.71M
P/E Ratio
6.61
Dividend Yield
-
Dividend
-
Upcoming
Earnings
7MayExpected
Expected EPS
-0.182
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-80.44MNet Income
Analyst Ratings
$6.07Average Price Target
The highest estimate is 6.07.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 2TK.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap22.63B
Regenxbio
RGNX
Mkt Cap645.07M
Ionis Pharmaceuticals
IONS
Mkt Cap12.03B
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Novartis
NVS
Mkt Cap237.61B
AMGEN
AMGN
Mkt Cap160.66B
Gilead Sciences
GILD
Mkt Cap148.78B
Pfizer
PFE
Mkt Cap140.15B
About
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical trials for the treatment of ALS, and Phase 2 clinical trials in islet cell transplantation for the treatment of type 1 diabetes. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Show more...
CEO
Dr. David-Alexandre C. Gros M.D., Ph.D.
Employees
31
Country
US
ISIN
US28617K1016
WKN
000A2QL00
Listings
0 Comments
Share your thoughts
FAQ
What is Eledon Pharmaceuticals stock price today?▼
The current price of 2TK.F is €2.5 EUR — it has decreased by -3.85% in the past 24 hours. Watch Eledon Pharmaceuticals stock price performance more closely on the chart.
What is Eledon Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Eledon Pharmaceuticals stocks are traded under the ticker 2TK.F.
Is Eledon Pharmaceuticals stock price growing?▼
2TK.F stock has risen by +2.46% compared to the previous week, the month change is a +9.65% rise, over the last year Eledon Pharmaceuticals has showed a -14.38% decrease.
What is Eledon Pharmaceuticals market cap?▼
Today Eledon Pharmaceuticals has the market capitalization of 149.71M
When is the next Eledon Pharmaceuticals earnings date?▼
Eledon Pharmaceuticals is going to release the next earnings report on May 07, 2026.
What were Eledon Pharmaceuticals earnings last quarter?▼
2TK.F earnings for the last quarter are -0.1 EUR per share, whereas the estimation was -0.18 EUR resulting in a +45.9% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Eledon Pharmaceuticals revenue for the last year?▼
Eledon Pharmaceuticals revenue for the last year amounts to 0 EUR.
What is Eledon Pharmaceuticals net income for the last year?▼
2TK.F net income for the last year is -80.44M EUR.
How many employees does Eledon Pharmaceuticals have?▼
As of April 02, 2026, the company has 31 employees.
In which sector is Eledon Pharmaceuticals located?▼
Eledon Pharmaceuticals operates in the Health Care sector.
When did Eledon Pharmaceuticals complete a stock split?▼
The last stock split for Eledon Pharmaceuticals was on October 05, 2020 with a ratio of 1:18.
Where is Eledon Pharmaceuticals headquartered?▼
Eledon Pharmaceuticals is headquartered in Irvine, US.